New Hope for SPG47: BlackfinBio’s BFB-101 Gene Therapy Advances with FDA Approval
Clinical Trials
How Ring's Anellovectors Could Change the Treatment of Genetic Diseases
Genetic
The Next Frontier: Revolutionizing Gene Therapy with Anellovirus-Based Vectors
Pioneering Gene Therapy Shows Promising Results in Parkinson’s Disease Trial
Mitochondrial Discovery: A New Era in Parkinson's Prevention and Treatment
Researchers discover key connection between DNA replication and cancer
Could Utilizing DNA Repair Mechanisms Be an Option in Cancer Treatment?
Subscribe for the latest news and events
Most Popular
Improving Everolimus Safety in Oncology: Missed Opportunities in Risk Minimization
FDA Approves Wegovy to Reduce Risk of Heart Problems in Obese Adults
Targeting the ‘Don’t Eat Me’ Signal: The Future of Macrophage Checkpoint Inhibitors
A New Era in Liver Disease: FDA Approves First Medication 'Rezdiffra' for NASH
Zongertinib Gains FDA Accelerated Approval for HER2+ NSCLC with 75% ORR
Exploring the Transformative Power of AI in Drug Discovery: A report by S&P Global
NETTER-2 Trial: Lutathera Cuts Risk of Death by 72% in Neuroendocrine Tumor Treatment
FDA Grants Accelerated Approval to Semaglutide for MASH with Liver Fibrosis
EpCAM-Targeting ADC CX-2051 Shows Promising Efficacy in Advanced Colorectal Cancer
Bayer Poised for Landmark Year with Blockbuster Treatment Advances Across Key Diseases
NEJM Study Confirms Low-Dose Aspirin Halves Recurrence in Colorectal Cancer
Transformative One-Time Gene Therapy: FDA Approves Pfizer's BEQVEZ, for Hemophilia B
FDA Approves Groundbreaking CAR T Cell Therapy, Abecma, for Multiple Myeloma
New Horizon in Food Allergy Treatment: FDA Approves Xolair for All Ages
FDA Approves Carvykti as Targeted CAR-T Cell Therapy for Multiple Myeloma
